{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:06:00Z","timestamp":1792598760388,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>General practitioners (GPs) should regularly review patients\u2019 medications and, when they are potentially harmful or no longer necessary, implement deprescribing approach. We aimed to assess the perceptions and potential barriers to deprescribing among Italian GPs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>GPs were invited to participate in an observational cross-sectional study through an online survey containing 20 questions addressing attitudes towards deprescribing, including physicians\u2019 perceptions, potential barriers, and how this process is addressed in daily clinical practice. The survey, accessible for responses from 4th May 2023 to 15th January 2024, was distributed through social media, networks, medical associations, and involving primary care departments of local health authorities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over 8 months, 617 answers were collected. Less than 2% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911) reported to not implement deprescribing interventions in daily practice, primarily due to perceived insufficient experience (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097) or lack of specific education (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096). Conversely, 23.1%(\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009142) of respondents reported frequently or very frequently implementing deprescribing. Among barriers, GPs reported difficulties in dealing with specialists (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009438, 71.7%), distrust of patients in drug discontinuation (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009326, 53.4%), poor availability of deprescribing guidelines (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009231, 37.8%), and time constraints (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009213, 34.9%). Guidelines and targeted training were mostly demanded (by 66.1% and 59.6%, respectively). Regarding specific drug classes, the proportion of GPs reporting to frequently implement deprescribing for proton pump inhibitors was 51.8% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009313), while percentage was lower for benzodiazepines (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009166, 27.4%), bisphosphonates (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009147, 24.3%), statins (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009128, 21.2%), antihypertensives (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009108, 17.9%), and antidepressants (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200996, 15.9%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study shows that while GPs recognize the importance of deprescribing, however, they face significant barriers, including a lack in targeted education and specific guidelines to enhance their confidence and knowledge in implementing this process effectively in daily clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12875-025-03042-2","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:26:29Z","timestamp":1766499989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Attitudes and confidence toward deprescribing: a survey among Italian general practitioners"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6475-2418","authenticated-orcid":false,"given":"Andrea","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8881-5912","authenticated-orcid":false,"given":"Stefano","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-0074","authenticated-orcid":false,"given":"Lara","family":"Perrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4231-4150","authenticated-orcid":false,"given":"Federica","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7107-243X","authenticated-orcid":false,"given":"Elena","family":"Olmastroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8633-5650","authenticated-orcid":false,"given":"Enrica","family":"Menditto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8209-8878","authenticated-orcid":false,"given":"Valentina","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3605-8581","authenticated-orcid":false,"given":"Ilaria","family":"Ardoino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6802-8710","authenticated-orcid":false,"given":"Carlotta","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-5361","authenticated-orcid":false,"given":"Manuela","family":"Casula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"2","key":"3042_CR1","first-page":"231","volume":"75","author":"M Pollock","year":"2007","unstructured":"Pollock M, Bazaldua OV, Dobbie AE. Appropriate prescribing of medications: an eight-step approach. Am Fam Physician. 2007;75(2):231\u20136.","journal-title":"Am Fam Physician"},{"key":"3042_CR2","unstructured":"Takhar S, Nelson N. Deprescribing as a Patient Safety Strategy. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2021.\u00a0https:\/\/psnet.ahrq.gov\/primer\/deprescribing-patient-safety-strategy"},{"key":"3042_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2022.104074","volume":"130","author":"A Mouazer","year":"2022","unstructured":"Mouazer A, Tsopra R, Sedki K, Letord C, Lamy JB. Decision-support systems for managing polypharmacy in the elderly: a scoping review. J Biomed Inf. 2022;130:104074.","journal-title":"J Biomed Inf"},{"issue":"1","key":"3042_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.mayocp.2020.06.012","volume":"96","author":"RW Hoel","year":"2021","unstructured":"Hoel RW, Giddings Connolly RM, Takahashi PY. Polypharmacy management in older patients. Mayo Clin Proc. 2021;96(1):242\u201356.","journal-title":"Mayo Clin Proc"},{"key":"3042_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev-med-070822-101947","volume":"75","author":"W Thompson","year":"2024","unstructured":"Thompson W, McDonald EG. Polypharmacy and deprescribing in older adults. Annu Rev Med. 2024;75:113\u201327.","journal-title":"Annu Rev Med"},{"issue":"11","key":"3042_CR6","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.jamda.2023.07.016","volume":"24","author":"D Zhou","year":"2023","unstructured":"Zhou D, Chen Z, Tian F. Deprescribing interventions for older patients: a systematic review and meta-analysis. J Am Med Dir Assoc. 2023;24(11):1718\u201325.","journal-title":"J Am Med Dir Assoc"},{"issue":"32","key":"3042_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/AAFO2475","volume":"26","author":"J Reeve","year":"2022","unstructured":"Reeve J, Maden M, Hill R, Turk A, Mahtani K, Wong G, et al. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis. Health Technol Assess. 2022;26(32):1\u2013148.","journal-title":"Health Technol Assess"},{"issue":"9","key":"3042_CR8","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1111\/jgs.17273","volume":"69","author":"KM Zimmerman","year":"2021","unstructured":"Zimmerman KM, Linsky AM. A narrative review of updates in deprescribing research. J Am Geriatr Soc. 2021;69(9):2619\u201324.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"3042_CR9","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s11606-020-06089-2","volume":"35","author":"HE Bloomfield","year":"2020","unstructured":"Bloomfield HE, Greer N, Linsky AM, Bolduc J, Naidl T, Vardeny O, et al. Deprescribing for community-dwelling older adults: a systematic review and meta-analysis. J Gen Intern Med. 2020;35(11):3323\u201332.","journal-title":"J Gen Intern Med"},{"key":"3042_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102237","volume":"95","author":"N Veronese","year":"2024","unstructured":"Veronese N, Gallo U, Boccardi V, Demurtas J, Michielon A, Taci X, et al. Efficacy of deprescribing on health outcomes: an umbrella review of systematic reviews with meta-analysis of randomized controlled trials. Ageing Res Rev. 2024;95:102237.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"3042_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11096-013-9871-z","volume":"36","author":"E Reeve","year":"2014","unstructured":"Reeve E, Wiese MD. Benefits of deprescribing on patients\u2019 adherence to medications. Int J Clin Pharm. 2014;36(1):26\u20139.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"3042_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-019-1031-4","volume":"19","author":"J Ulley","year":"2019","unstructured":"Ulley J, Harrop D, Ali A, Alton S, Fowler Davis S. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review. BMC Geriatr. 2019;19(1):15.","journal-title":"BMC Geriatr"},{"issue":"4","key":"3042_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40266-018-0536-4","volume":"35","author":"J Thillainadesan","year":"2018","unstructured":"Thillainadesan J, Gnjidic D, Green S, Hilmer SN. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials. Drugs Aging. 2018;35(4):303\u201319.","journal-title":"Drugs Aging"},{"issue":"1","key":"3042_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-021-02612-0","volume":"21","author":"A Mahlknecht","year":"2021","unstructured":"Mahlknecht A, Wiedermann CJ, Sandri M, Engl A, Valentini M, Vogele A, et al. Expert-based medication reviews to reduce polypharmacy in older patients in primary care: a northern-Italian cluster-randomised controlled trial. BMC Geriatr. 2021;21(1):659.","journal-title":"BMC Geriatr"},{"issue":"10","key":"3042_CR15","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1111\/jgs.19035","volume":"72","author":"M Carollo","year":"2024","unstructured":"Carollo M, Crisafulli S, Vitturi G, Besco M, Hinek D, Sartorio A, et al. Clinical impact of medication review and deprescribing in older inpatients: a systematic review and meta-analysis. J Am Geriatr Soc. 2024;72(10):3219\u201338.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"3042_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.31128\/AJGP-08-22-6547","volume":"52","author":"HW Quek","year":"2023","unstructured":"Quek HW, Page A, Potter K, Etherton-Beer C. Deprescribing considerations for older people in general practice. Aust J Gen Pract. 2023;52(4):173\u201380.","journal-title":"Aust J Gen Pract"},{"issue":"1","key":"3042_CR17","first-page":"7","volume":"99","author":"B Farrell","year":"2019","unstructured":"Farrell B, Mangin D. Deprescribing is an essential part of good prescribing. Am Fam Physician. 2019;99(1):7\u20139.","journal-title":"Am Fam Physician"},{"issue":"1","key":"3042_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-020-01255-1","volume":"21","author":"N Gerlach","year":"2020","unstructured":"Gerlach N, Michiels-Corsten M, Viniol A, Schleef T, Junius-Walker U, Krause O, et al. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study. BMC Fam Pract. 2020;21(1):183.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"3042_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.32481\/djph.2017.03.012","volume":"3","author":"M Savoy","year":"2017","unstructured":"Savoy M, Faafp, Fabc, Cpe C, Faapl, Hazlett-O\u2019Brien C, Rapacciuolo J. The role of primary care physicians in managing chronic disease. Dela J Public Health. 2017;3(1):86\u201393.","journal-title":"Dela J Public Health"},{"issue":"7","key":"3042_CR20","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"By the American Geriatrics Society Beers Criteria Update Expert P","year":"2023","unstructured":"By the American Geriatrics Society Beers Criteria Update Expert P. American geriatrics society 2023 updated AGS beers Criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052\u201381.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"3042_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","volume":"14","author":"D O\u2019Mahony","year":"2023","unstructured":"O\u2019Mahony D, Cherubini A, Guiteras AR, Denkinger M, Beuscart JB, Onder G, et al. Stopp\/start criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14(4):625\u201332.","journal-title":"Eur Geriatr Med"},{"issue":"5","key":"3042_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40266-023-01024-6","volume":"40","author":"F Pazan","year":"2023","unstructured":"Pazan F, Weiss C, Wehling M, Members FEP. The EURO-FORTA (Fit fOR the Aged) list version 2: consensus validation of a clinical tool for improved pharmacotherapy in older adults. Drugs Aging. 2023;40(5):417\u201326.","journal-title":"Drugs Aging"},{"issue":"1\u20132","key":"3042_CR23","first-page":"3","volume":"120","author":"NK Mann","year":"2023","unstructured":"Mann NK, Mathes T, Sonnichsen A, Pieper D, Klager E, Moussa M, et al. Potentially inadequate medications in the elderly: PRISCUS 2.0. Dtsch Arztebl Int. 2023;120(1\u20132):3\u201310.","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"3042_CR24","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1111\/hex.13630","volume":"25","author":"C McCarthy","year":"2022","unstructured":"McCarthy C, Pericin I, Smith SM, Kiely B, Moriarty F, Wallace E, et al. Patient and general practitioner experiences of implementing a medication review intervention in older people with multimorbidity: process evaluation of the SPPiRE trial. Health Expect. 2022;25(6):3225\u201337.","journal-title":"Health Expect"},{"key":"3042_CR25","doi-asserted-by":"crossref","unstructured":"McCarthy C, Clyne B, Boland F, Moriarty F, Flood M, Wallace E, Smith SM; SPPiRE Study team. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial. PLoS Med. 2022;19(1):e1003862.\u00a0https:\/\/10.0.5.91\/journal.pmed.1003862.","DOI":"10.1371\/journal.pmed.1003862"},{"issue":"3","key":"3042_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/17512433.2020.1730812","volume":"13","author":"M Sawan","year":"2020","unstructured":"Sawan M, Reeve E, Turner J, Todd A, Steinman MA, Petrovic M, et al. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review. Expert Rev Clin Pharmacol. 2020;13(3):233\u201345.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"3042_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15657-x","volume":"12","author":"M Stuhec","year":"2022","unstructured":"Stuhec M, Zorjan K. Clinical pharmacist interventions in ambulatory psychogeriatric patients with excessive polypharmacy. Sci Rep. 2022;12(1):11387.","journal-title":"Sci Rep"},{"issue":"2","key":"3042_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11096-024-01840-9","volume":"47","author":"M Stuhec","year":"2025","unstructured":"Stuhec M. Medication reconciliation and seamless care led by clinical pharmacists in Slovenia: a national reimbursed program ensuring safe and effective transition of care. Int J Clin Pharm. 2025;47(2):239\u201346.","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"3042_CR29","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/s11096-021-01306-2","volume":"43","author":"M Stuhec","year":"2021","unstructured":"Stuhec M. Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement. Int J Clin Pharm. 2021;43(6):1722\u20137.","journal-title":"Int J Clin Pharm"},{"key":"3042_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13206283","author":"A Rossi","year":"2024","unstructured":"Rossi A, Perrella L, Scotti S, Olmastroni E, Galimberti F, Ardoino I, et al. Approaches to deprescribing proton pump inhibitors in clinical practice: a systematic review. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13206283.","journal-title":"J Clin Med"},{"issue":"2","key":"3042_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/ijpp\/riad001","volume":"31","author":"DA Okeowo","year":"2023","unstructured":"Okeowo DA, Zaidi STR, Fylan B, Alldred DP. Barriers and facilitators of implementing proactive deprescribing within primary care: a systematic review. Int J Pharm Pract. 2023;31(2):126\u201352.","journal-title":"Int J Pharm Pract"},{"key":"3042_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1430879","author":"M Casula","year":"2025","unstructured":"Casula M, Ardoino I, Pierini L, Perrella L, Scotti S, Mucherino S, et al. Inappropriate prescribing of drugs for peptic ulcer and gastro-esophageal reflux disease remains a matter of concern: results from the LAPTOP-PPI cluster randomized trial. Front Pharmacol. 2025. https:\/\/doi.org\/10.3389\/fphar.2024.1430879.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3042_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/bcp.15906","volume":"90","author":"DZ Anlay","year":"2024","unstructured":"Anlay DZ, Paque K, Van Leeuwen E, Cohen J, Dilles T. Tools and guidelines to assess the appropriateness of medication and aid deprescribing: an umbrella review. Br J Clin Pharmacol. 2024;90(1):12\u2013106.","journal-title":"Br J Clin Pharmacol"},{"key":"3042_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.803809","volume":"13","author":"I Ardoino","year":"2022","unstructured":"Ardoino I, Casula M, Molari G, Mucherino S, Orlando V, Menditto E, et al. Prescription appropriateness of drugs for peptic ulcer and gastro-esophageal reflux disease: baseline assessment in the LAPTOP-PPI cluster randomized trial. Front Pharmacol. 2022;13:803809.","journal-title":"Front Pharmacol"},{"issue":"681","key":"3042_CR35","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.3399\/bjgp19X701801","volume":"69","author":"H Carrier","year":"2019","unstructured":"Carrier H, Zaytseva A, Bocquier A, Villani P, Verdoux H, Fortin M, et al. GPs\u2019 management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of gps in France. Br J Gen Pract. 2019;69(681):e270-8.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"3042_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-024-02299-3","volume":"25","author":"T Coelho","year":"2024","unstructured":"Coelho T, Rosendo I, Seica Cardoso C. Evaluation of deprescription by general practitioners in elderly people with different levels of dependence: cross-sectional study. BMC Prim Care. 2024;25(1):78.","journal-title":"BMC Prim Care"},{"issue":"1","key":"3042_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-023-04155-y","volume":"23","author":"P Nizet","year":"2023","unstructured":"Nizet P, Evin A, Brociero E, Vigneau CV, Huon JF. Outcomes in deprescribing implementation trials and compliance with expert recommendations: a systematic review. BMC Geriatr. 2023;23(1):428.","journal-title":"BMC Geriatr"},{"issue":"1","key":"3042_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-016-0551-7","volume":"17","author":"BB Bolmsjo","year":"2016","unstructured":"Bolmsjo BB, Palagyi A, Keay L, Potter J, Lindley RI. Factors influencing deprescribing for residents in advanced care facilities: insights from general practitioners in Australia and Sweden. BMC Fam Pract. 2016;17(1):152.","journal-title":"BMC Fam Pract"},{"key":"3042_CR39","doi-asserted-by":"publisher","unstructured":"Rossi PR, Hegarty SE, Maio V, Lombardi M, Pizzini A, Mozzone A, Uberti M, Miozzo SJGC. General practitioner attitudes and confidence to deprescribing for elderly patients. Geriatric Care. 2020;6(1).\u00a0https:\/\/doi.org\/10.4081\/gc.2020.8703.","DOI":"10.4081\/gc.2020.8703"},{"issue":"6","key":"3042_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1071\/PY18056","volume":"24","author":"R Gillespie","year":"2018","unstructured":"Gillespie R, Mullan J, Harrison L. Deprescribing for older adults in Australia: factors influencing gps. Aust J Prim Health. 2018;24(6):463\u20139.","journal-title":"Aust J Prim Health"},{"issue":"1","key":"3042_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-023-00132-2","volume":"10","author":"M Robinson","year":"2024","unstructured":"Robinson M, Mokrzecki S, Mallett AJ. Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review. NPJ Aging. 2024;10(1):6.","journal-title":"NPJ Aging"},{"issue":"11","key":"3042_CR42","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jamda.2018.06.021","volume":"19","author":"H Dills","year":"2018","unstructured":"Dills H, Shah K, Messinger-Rapport B, Bradford K, Syed Q. Deprescribing medications for chronic diseases management in primary care settings: A systematic review of randomized controlled trials. J Am Med Dir Assoc. 2018;19(11):923\u2013e935922.","journal-title":"J Am Med Dir Assoc"},{"issue":"Suppl 1","key":"3042_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.33393\/grhta.2024.2970","volume":"11","author":"M Pani","year":"2024","unstructured":"Pani M. The role of the hospital pharmacist to guarantee access and continuity of care for the management of epilepsy. Global and Regional Health Technology Assessment. 2024;11(Suppl 1):8\u201310.","journal-title":"Global and Regional Health Technology Assessment"},{"issue":"1","key":"3042_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-020-01953-6","volume":"21","author":"KT Jungo","year":"2021","unstructured":"Jungo KT, Mantelli S, Rozsnyai Z, Missiou A, Kitanovska BG, Weltermann B, et al. General practitioners\u2019 deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries. BMC Geriatr. 2021;21(1):19.","journal-title":"BMC Geriatr"},{"issue":"4","key":"3042_CR45","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2021.12.247","volume":"162","author":"LE Targownik","year":"2022","unstructured":"Targownik LE, Fisher DA, Saini SD. AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review. Gastroenterology. 2022;162(4):1334\u201342.","journal-title":"Gastroenterology"},{"issue":"1","key":"3042_CR46","first-page":"17","volume":"64","author":"LM Bjerre","year":"2018","unstructured":"Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman-Wilms L, Rojas-Fernandez C, Sinha S, Thompson W, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline. Can Fam Physician. 2018;64(1):17\u201327.","journal-title":"Can Fam Physician"},{"issue":"2","key":"3042_CR47","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40670-022-01704-9","volume":"33","author":"B Farrell","year":"2023","unstructured":"Farrell B, Raman-Wilms L, Sadowski CA, Mallery L, Turner J, Gagnon C, et al. A proposed curricular framework for an interprofessional approach to deprescribing. Med Sci Educ. 2023;33(2):551\u201367.","journal-title":"Med Sci Educ"},{"issue":"2","key":"3042_CR48","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11096-022-01515-3","volume":"45","author":"AB Almarsdottir","year":"2023","unstructured":"Almarsdottir AB, Haq R, Norgaard J. Prioritizing patients for medication review by emergency department pharmacists: a multi-method study. Int J Clin Pharm. 2023;45(2):387\u201396.","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"3042_CR49","first-page":"1009","volume":"27","author":"MA Bishop","year":"2021","unstructured":"Bishop MA, Chang HY, Kitchen C, Weiner JP, Kharrazi H, Shermock KM. Development of measurable criteria to identify and prioritize patients for inclusion in comprehensive medication management programs within primary care settings. J Manag Care Spec Pharm. 2021;27(8):1009\u201318.","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"3042_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-024-02465-7","volume":"25","author":"PJC Stuijt","year":"2024","unstructured":"Stuijt PJC, Heringa M, van Dijk L, Faber A, Burgers JS, Feenstra TL, et al. Effects of a multicomponent communication training to involve older people in decisions to deprescribe cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluation. BMC Prim Care. 2024;25(1):210.","journal-title":"BMC Prim Care"},{"issue":"11","key":"3042_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-081305","volume":"13","author":"K Warmoth","year":"2023","unstructured":"Warmoth K, Rees J, Day J, Cockcroft E, Aylward A, Pollock L, et al. Determinants of implementing deprescribing for older adults in English care homes: a qualitative interview study. BMJ Open. 2023;13(11):e081305.","journal-title":"BMJ Open"},{"issue":"1","key":"3042_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-018-0856-9","volume":"19","author":"S Mantelli","year":"2018","unstructured":"Mantelli S, Jungo KT, Rozsnyai Z, Reeve E, Luymes CH, Poortvliet RKE, et al. How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study. BMC Fam Pract. 2018;19(1):169.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"3042_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-022-03279-x","volume":"22","author":"M Delara","year":"2022","unstructured":"Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):601.","journal-title":"BMC Geriatr"},{"key":"3042_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2021-001509","author":"A Elbeddini","year":"2021","unstructured":"Elbeddini A, Sawhney M, Tayefehchamani Y, Yilmaz Z, Elshahawi A, Josh Villegas J, et al. Deprescribing for all: a narrative review identifying inappropriate polypharmacy for all ages in hospital settings. BMJ Open Qual. 2021. https:\/\/doi.org\/10.1136\/bmjoq-2021-001509.","journal-title":"BMJ Open Qual"},{"key":"3042_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-13-56","volume":"13","author":"J Schuling","year":"2012","unstructured":"Schuling J, Gebben H, Veehof LJ, Haaijer-Ruskamp FM. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. a qualitative study. BMC Fam Pract. 2012;13:56.","journal-title":"BMC Fam Pract"},{"key":"3042_CR56","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jad.2024.04.060","volume":"356","author":"E Van Leeuwen","year":"2024","unstructured":"Van Leeuwen E, Maund E, Woods C, Bowers H, Christiaens T, Kendrick T. Health care professional barriers and facilitators to discontinuing antidepressant use: a systematic review a","journal-title":"J Affect Disord"},{"key":"3042_CR57","doi-asserted-by":"crossref","unstructured":"Del-Pino M, Sanz EJ. Analysis of deprescription strategies of proton pump inhibitors inprimary care: a narrative review. Prim Health Care Res Dev. 2023;24:e14.","DOI":"10.1017\/S1463423623000026"},{"key":"3042_CR58","doi-asserted-by":"crossref","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research(COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","DOI":"10.1093\/intqhc\/mzm042"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-03042-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-025-03042-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-03042-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:03:41Z","timestamp":1766505821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12875-025-03042-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3042"],"URL":"https:\/\/doi.org\/10.1186\/s12875-025-03042-2","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study did not require ethics committee approval as it did not involve sensitive or health-related data, in compliance with the Italian Data Protection Code and GDPR. Participation was anonymous, with informed consent obtained via the survey\u2019s introductory page.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare no support from any organization for the submitted work. MC received honoraria for consultancy or speaker bureau from Sobi and Ultragenyx.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"403"}}